Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 January 2025 | Story Lacea Loader | Photo Supplied
Jurie Blignaut
Jurie Blignaut, top achiever in the 2024 matric exams for quintile four schools in SA and finalist of the UFS 2024 Matriculant of the Year competition.

The University of the Free State (UFS) is proud to announce that the top achiever in the 2024 matric exams for quintile four schools in the country, Jurie Blignaut, will be studying towards an MBChB at the UFS from 2025.

Blignaut, a pupil of the Rustenburg High School, was one of the 14 finalists in the 2024 UFS Matriculant of the Year competition.

“Congratulations to Jurie on this wonderful achievement. We look forward to welcoming him and our cohort of 2025 first-year students to our campuses,” says Prof Anthea Rhoda, acting Vice-Chancellor and Principal of the UFS. 

Boasting 11 distinctions and an average of 96,5%, Blignaut is not only an exceptional academic achiever but also participates in several cultural activities. He was the winner of the Kovsie Alumni Trust’s special award for personal cultural achievement in the final round of the competition. This head boy of his school is an excellent public speaker and musician. 

Blignaut’s highest achievement in public speaking was his national second place in last year’s ATKV public speaking competition in the section for Afrikaans home language. He plays the cello and has performed solo with the Pretoria Symphony Orchestra, was part of the school choir and band, and participated in the Stellenbosch International Chamber Music Festival. 

“On behalf of the university management, I would also like to congratulate Dr Mantlhake Maboya, MEC for Education in the Free State, and her executive team on the Free State being the top-achieving province in South Africa,” says Prof Rhoda. 

Other finalists in the 2024 UFS Matriculant of the Year competition who excelled during the matric exams include Susan Bender from Voortrekker High School – top achiever in the Free State province – and Chris Goosen from Grey College Secondary School, who is also one of the top achievers in the Free State. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept